These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 5135370)

  • 1. [Evaluation of the efficacy and side effects of the contraceptive containing 0.5 mg of norethindrone and 0.1 mg of mestranol in a family planning clinic].
    de Sampaio Júnior LF; Dib JE; Pereira VM; Neme B
    Matern Infanc (Sao Paulo); 1971; 30(1):65-9. PubMed ID: 5135370
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-term study of oral contraception with norethindrone 2 mg. and mestranol 0.1 mg.
    Hutcherson WP; Schwartz HA; Weathers W
    Fertil Steril; 1966; 17(1):59-67. PubMed ID: 5901012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term evaluation of two oral contraceptives.
    Hutcherson WP; Schwartz HA; Weathers W; McGuire JE
    Fertil Steril; 1967; 18(5):616-31. PubMed ID: 6037450
    [No Abstract]   [Full Text] [Related]  

  • 4. Rationale for a new triphasic oral contraceptive.
    Pasquale SA
    Int J Fertil; 1986; 31 SU [UPDATE]():13-9. PubMed ID: 2899554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new long dosage oral contraceptive, 1.0 mg. norethindrone. A preliminary study.
    Milton MD; Nelson JH
    Pac Med Surg; 1967; 75(2):127-31. PubMed ID: 6039890
    [No Abstract]   [Full Text] [Related]  

  • 6. Methodology in oral contraceptive research.
    Greaney MO; Taber BZ; Bessler SA
    Fertil Steril; 1968; 19(3):339-43. PubMed ID: 4869628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new low-dose combination oral contraceptive.
    Tyler ET
    Minn Med; 1969 Nov; 52(11):1833-6. PubMed ID: 5354091
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical study of S-3800E tablets, a combination of norethindrone and mestranol in a small dosage].
    Tokuda G; Murakami A; Higashiyama S; Obata T; Ishihara S
    Saishin Igaku; 1969 Mar; 24(3):644-56. PubMed ID: 5772841
    [No Abstract]   [Full Text] [Related]  

  • 9. Oral contraceptives during immediate postabortal period.
    Niswonger JW; London GD; Anderson GV; Wolfe L
    Obstet Gynecol; 1968 Sep; 32(3):325-7. PubMed ID: 5742114
    [No Abstract]   [Full Text] [Related]  

  • 10. [Use of an estroprogestinic association (norethindrone 2 mg and mestranol 100 gamma) in dysfunctional gynecologic syndromes].
    Capra A; Trompeo P; Garetto A; Campagnoli C
    Minerva Ginecol; 1969 Aug; 21(15):967-86. PubMed ID: 5404341
    [No Abstract]   [Full Text] [Related]  

  • 11. [Evaluation of norethindrone combined with mestranol (S-3800 C) as an oral contraceptive].
    Seiga K
    Iryo; 1968 Apr; 22(4):444-52. PubMed ID: 5686370
    [No Abstract]   [Full Text] [Related]  

  • 12. The length of the first three menstrual cycles after combined oral contraceptive treatment.
    Larsson-Cohn U
    Acta Obstet Gynecol Scand; 1969; 48(3):416-22. PubMed ID: 5370780
    [No Abstract]   [Full Text] [Related]  

  • 13. Marginal-dose contraception in the puerperium.
    Wentz WB; Jaffe RM; Foxx RM
    Obstet Gynecol; 1966 Sep; 28(3):369-72. PubMed ID: 5950532
    [No Abstract]   [Full Text] [Related]  

  • 14. Ovanon. A new sequential oral contraceptive.
    Rice-Wray E; Peña A; Maqueo M
    Int J Fertil; 1968; 13(4):453-9. PubMed ID: 5700405
    [No Abstract]   [Full Text] [Related]  

  • 15. [Experiences with different doses of Ovosiston preparations within the scope of marital and sexual counseling. Individual therapy with oral contraceptives].
    Ebeling K; Kühndel K; Rothe K
    Dtsch Gesundheitsw; 1971 Jan; 26(1):31-4. PubMed ID: 4106517
    [No Abstract]   [Full Text] [Related]  

  • 16. Ovarian morphology following cyclic norethindrone-mestranol therapy.
    Zussman WV; Forbes DA; Carpenter RJ
    Am J Obstet Gynecol; 1967 Sep; 99(1):99-105. PubMed ID: 6034978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship of clotting factors to dosage levels of estrogen and progestogen-like combinations.
    Banks AL; Rutherford RN; Coburn WA; Welsh RL
    Int J Fertil; 1966; 11(3):277-80. PubMed ID: 5967993
    [No Abstract]   [Full Text] [Related]  

  • 18. A new sequential oral contraceptive evaluated.
    Loewenberg LS
    Pa Med; 1966 Jan; 69(1):37-9. PubMed ID: 5900565
    [No Abstract]   [Full Text] [Related]  

  • 19. Cytohormonal findings in patients using various forms of contraception.
    Reyniak JV; Sedlis A; Stone D; Connell E
    Acta Cytol; 1969 Jun; 13(6):315-22. PubMed ID: 4184413
    [No Abstract]   [Full Text] [Related]  

  • 20. [Experiences with Ovosiston in marital and sexual counseling in a district hospital in the period Jan. 1, 1967-Dec. 31, 1968].
    Keil G
    Z Arztl Fortbild (Jena); 1970 May; 64(10):500-1. PubMed ID: 4106558
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.